Pancreatic Ductal Adenocarcinoma Latest Advances

Longitudinal analysis of matched patient biospecimens reveals Neural Reprogramming of Cancer-Associated Fibroblasts Following Chemotherapy in Pancreatic Ductal Adenocarcinoma.

Journal: bioRxiv : the preprint server for biology

Published: January 23, 2026

Prevalence and impact of germline mutations in pancreatic ductal adenocarcinoma.

Journal: Tumori

Published: January 22, 2026

Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 21, 2026

Successful Resection of a Metachronous Liver Metastasis after Pancreatic Ductal Adenocarcinoma Surgery-A Case with Two-Year Recurrence-Free Survival

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

The combination of BCL-xL PROTAC and mTOR inhibitor sensitizes pancreatic ductal adenocarcinoma to KRAS G12D inhibitor treatment by enhancing apoptosis induction.

Journal: bioRxiv : the preprint server for biology

Published: January 16, 2026

Discussion of Survival Impact of Intraoperative CO2 Dysregulation in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma.

Journal: Journal of the American College of Surgeons

Published: January 15, 2026

Nanoparticles for Delivery of Encapsulated Drugs to Hypoxic Pancreatic Ductal Adenocarcinoma Cell Spheroids.

Journal: Molecular pharmaceutics

Published: January 14, 2026

Corrigendum to 'The hidden players: the mycobiome of pancreatic ductal adenocarcinoma tumors' [Microbiol. Res. 303 (2026) 128392].

Journal: Microbiological research

Published: January 13, 2026

Prognostic value of KRAS gene mutations in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.

Journal: Scandinavian journal of gastroenterology

Published: January 13, 2026

ASO Visual Abstract: Incidence of Venous Thromboembolism in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Chemotherapy.

Journal: Annals of surgical oncology

Published: January 08, 2026

Correction: Cancer-associated fibroblast-derived exosome leptin promotes malignant biological lineage in pancreatic ductal adenocarcinoma by regulating ABL2 via miR-224-3p.

Journal: Molecular biology reports

Published: January 06, 2026

Machine Learning-Based Identification of Blood Biomarkers that Distinguish Precachectic and Cachectic Patients with Pancreatic Ductal Adenocarcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: January 02, 2026